News

Filter

Current filters:

Dapsone

1 to 9 of 22 results

QLT closes Aczone deal with Allergan

21-07-2008

Canada's QLT says that its wholly-owned US subsidiary has completed the sale of its Aczone (dapsone)…

Aczone GelAllerganDapsoneEligardLeuprolide Acetate

Allergan acquires QLT acne treatment

16-06-2008

US drugmaker Allergan has acquired the rights to Aczone (dapsone) topical gel, for the treatment of acne,…

Aczone GelAllerganDapsone

GSK recalls Lapdap and halts Dacart R&D

10-03-2008

UK-based drug major GlaxoSmithKline is to stop selling the malaria drug Lapdap (chlorproguanil/dapsone)…

Aczone GelDapsoneGlaxoSmithKlineGSK

QLT's 1st-qtr 2007 EPS falls 54% on Visudyne

07-05-2007

Canadian drugmaker QLT says that its earnings per share in the first quarter of 2007 fell to $0.06 from…

Aczone GelDapsoneEligardLeuprolide AcetateVerteporfin InjVisudyne

GSK initiates Ph III trial for new malaria drugs

31-07-2006

UK drug major GlaxoSmithKline, together with Medicines for Malaria Venture (MMV), a non-profit organization…

Aczone GelArtemether Lumefantrine TabletsCoartemDapsoneGlaxoSmithKlineGSK

QLT acquires full rights to Aczone

11-07-2005

Canadian biopharmaceutical group QLT says it will acquire full rights to Aczone gel for the treatment…

Aczone GelDapsone

Atrix and Fujisawa Healthcare submit NDA for Aczone for acne

06-09-2004

The USA's Atrix Laboratories and co-development partner FujisawaHealthcare have submitted a New Drug…

Aczone GelDapsone

1 to 9 of 22 results

COMPANY SPOTLIGHT

Menarini

Back to top